Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Oruka Therapeutics, Inc.

NASDAQ: ORKA · Life Sciences · 12 alerts · CIK 907654

Share price
$99.24Close, Nov 16
Market cap
$6.73B
Shares outstanding
67.82MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Oruka Therapeutics, Inc. filings on SEC EDGAR ↗

4:03 PM ET 10-Q
Financial Results

Oruka Therapeutics Q3 2026 Results: Net Loss of $50M, Loss Widens

Oruka Therapeutics reported a net loss of $123.0 million for the nine months ended September 30, 2026, driven by $126.1 million in research and development expenses. The company significantly strengthened its balance sheet during the period, ending with $1.23 billion in total assets following a major common stock offering in April 2026 and ATM program activity.

Key figure
Net loss $50M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.